The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation. - Wikidata - awgldk - TriplyDB

The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.

The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.

http://www.wikidata.org/entity/Q45275091

about

Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles Minireview: Challenges and opportunities in development of PPAR agonists Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History).The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.Pleiotropic effects of thiazolidinediones.Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in mice Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.RXR Ligands Negatively Regulate Thrombosis and Hemostasis.New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker.Different Effects of Thiazolidinediones on In-Stent Restenosis and Target Lesion Revascularization after PCI: A Meta-Analysis of Randomized Controlled Trials.Non-genomic effects of nuclear receptors: insights from the anucleate platelet.Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.The cardiovascular safety of rosiglitazone AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone.Signaling Mechanisms of Selective PPAR Modulators in Alzheimer's Disease

P2860

Q26830366-69BAAAEB-DB23-4F78-AFB7-C0D2F416CDF9 Q33631921-DA4A4C21-CF39-4470-A761-AF78432096A5 Q34541875-CD25038B-1DCD-4B62-8326-A660D1324ACC Q34897476-4C7FB137-C5D8-48D6-8BA9-D9E005145EDA Q35864188-23074437-A2B2-4EB3-A5E9-DA6372D995BF Q35888976-CAC08863-84B3-468C-8841-849CBF0CBAAD Q36445381-7D722DC7-2798-4D12-9273-2B3DDF155495 Q36569766-AFCAE717-B44E-446E-9F9C-B90B1EBAC287 Q36679594-170A5A38-860A-4F25-AD2D-75AF28527A64 Q36909303-E347C6FB-FD74-4027-8554-8D6A184E0F60 Q37142044-4B1C6D9E-5447-4AD2-9D83-40143B4DC52B Q37547865-A159A7E0-6A67-4876-9AF3-7578B1D4AF1E Q38077284-119909DE-4562-44FE-B4FE-601E6AB98F38 Q38163612-0C4EEB05-CA31-480E-B384-2566C8CABDDD Q41871753-A72E5496-2F85-4CCB-B39A-77034D8CD2DD Q41928597-F39A881A-EE0C-4083-90AB-F14A6DE98F91 Q42290465-70DE68A1-F284-4FB4-97ED-5317027669D2 Q42592882-68CDCFF7-A279-4588-9CDC-1B6D33C499EA Q47104900-B602054D-705D-4A6D-89ED-30D6F5B588B4 Q49922734-F8127D8C-13E9-4D99-BABB-6EAA0B85B2F6 Q53624959-4CF6F057-3135-4A7C-8DEC-C4428D395E1E Q54152623-F8A4267C-10E5-4FE9-BD91-D89AC56025EC Q55034947-51B3B3AB-F6FE-42C1-A552-7ED38F9729D9 Q58699276-517DA1A9-2376-44DC-8F2D-1C1F104D8F94

P2860

The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.

http://www.wikidata.org/entity/Q45275091

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@en

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@nl

type

label

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@en

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@nl

prefLabel

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@en

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@nl

P1433

Q45275091-685A582F-3720-4C7C-AF14-E53888E4D695

P1476

Q45275091-DE587ADA-F004-4078-98F9-5F8D34B53233

P2093

Q45275091-124B2039-A904-4FC3-AAAD-DEE4F0688C54

Q45275091-35A332E7-FACB-46B8-82C3-F1381F6B5E3A

Q45275091-6B650B94-D2E9-4B91-8E03-B3C0474FFF1A

Q45275091-9837A582-CD10-4D83-978A-7955755260C1

Q45275091-AF611FFB-400D-432E-B281-DB03F9AEEF3A

Q45275091-B48B4D1D-9CB5-4A6B-B931-AEF73007804B

Q45275091-F7D46103-FC46-4366-B292-7E29ACAB3DF6

Q45275091-FC6C3585-36EA-450D-A684-D38F7BBB5D0C

P304

Q45275091-E60965CD-04A8-4B6A-98AB-F75B3F7A1209

P31

Q45275091-6587510B-F0B2-448A-BA1B-46D7AA7526F9

P356

Q45275091-6F256D72-F7D5-4AFF-B272-8E01F04B1BF8

P433

Q45275091-735AE964-B6E4-4C40-8B97-6530D13C14E8

P478

Q45275091-E8A0A9C0-F7F2-42EF-828A-7DA7909686B4

P577

Q45275091-3A76C7A4-9DCC-46BC-BFA6-A58C17427ADD

P5875

Q45275091-F636A7BA-1B1C-400A-A537-6139F100E04C

P698

Q45275091-B8D6401D-BCDC-486A-B37C-DD64D1E23970

P356

J.CARDIORES.2004.11.027

P1433

Cardiovascular Research

P1476

The effects of PPAR-gamma liga ...... d arterial thrombus formation.

@en

P2093

Anjan K Sinha

http://www.w3.org/2001/XMLSchema#string

Dayuan Li

http://www.w3.org/2001/XMLSchema#string

Francesco Romeo

http://www.w3.org/2001/XMLSchema#string

Jawahar L Mehta

http://www.w3.org/2001/XMLSchema#string

Kui Chen

http://www.w3.org/2001/XMLSchema#string

Nandita Sinha

http://www.w3.org/2001/XMLSchema#string

Xingjiang Zhang

http://www.w3.org/2001/XMLSchema#string

Yin Wang

http://www.w3.org/2001/XMLSchema#string

P304

907-912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CARDIORES.2004.11.027

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8011319

http://www.w3.org/2001/XMLSchema#string

P698

15721871

http://www.w3.org/2001/XMLSchema#string